High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors.

Clinical and experimental evidence indicates that tumor-associated macrophages (TAMs) promote malignant progression. In breast cancer, TAMs enhance tumor angiogenesis, tumor cell invasion, matrix remodeling, and immune suppression against the tumor. In this study, we examined late-stage mammary tumors from a transgenic mouse model of breast cancer. We used flow cytometry under conditions that minimized gene expression changes to isolate a rigorously defined TAM population previously shown to be associated with invasive carcinoma cells. The gene expression signature of this population was compared with a similar population derived from spleens of non-tumor-bearing mice using high-density oligonucleotide arrays. Using stringent selection criteria, transcript abundance of 460 genes was shown to be differentially regulated between the two populations. Bioinformatic analyses of known functions of these genes indicated that formerly ascribed TAM functions, including suppression of immune activation and matrix remodeling, as well as multiple mediators of tumor angiogenesis, were elevated in TAMs. Further bioinformatic analyses confirmed that a pure and valid TAM gene expression signature in mouse tumors could be used to assess expression of TAMs in human breast cancer. The data derived from these more physiologically relevant autochthonous tumors compared with previous studies in tumor xenografts suggest tactics by which TAMs may regulate tumor angiogenesis and thus provide a basis for exploring other transcriptional mediators of TAM trophic functions within the tumor microenvironment.

[1]  R. Cardiff,et al.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.

[2]  P. Validire,et al.  Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer. , 1994, British Journal of Cancer.

[3]  S M Schwartz,et al.  Macrophages express osteopontin during repair of myocardial necrosis. , 1994, The American journal of pathology.

[4]  F. Beuvon,et al.  Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. , 1994, Journal of the National Cancer Institute.

[5]  E. Manseau,et al.  Osteopontin expression and distribution in human carcinomas. , 1994, The American journal of pathology.

[6]  B. Kacinski,et al.  CSF-1 and its receptor in ovarian, endometrial and breast cancer. , 1995, Annals of medicine.

[7]  G. Stamp,et al.  The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. , 1995, The Journal of clinical investigation.

[8]  J. Pollard,et al.  The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[10]  R. Jakesz,et al.  Tumour-associated macrophages in breast cancer and their prognostic correlations , 1998 .

[11]  J. F. Harris,et al.  Osteopontin expression in a group of lymph node negative breast cancer patients , 1998, International journal of cancer.

[12]  C. Murry,et al.  Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. , 1998, The American journal of pathology.

[13]  S. Nishikawa,et al.  Macrophage Lineage Cells in Inflammation: Characterization by Colony-Stimulating Factor-1 (CSF-1) Receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) Expression , 1998 .

[14]  S. Nishikawa,et al.  Macrophage lineage cells in inflammation: characterization by colony-stimulating factor-1 (CSF-1) receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) expression. , 1998, Blood.

[15]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Lo,et al.  Influence of lymphocytes on the presence and organization of dendritic cell subsets in the spleen. , 1999, Journal of immunology.

[17]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[18]  J. Pollard,et al.  Postnatal mammary gland development requires macrophages and eosinophils. , 2000, Development.

[19]  H. Saji,et al.  Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[22]  H. Saji,et al.  Significant correlation of monocyte chemoattractant protein‐1 expression with neovascularization and progression of breast carcinoma , 2001, Cancer.

[23]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[24]  Noam Brown,et al.  The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.

[25]  J. Pollard,et al.  Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development , 2002, Breast Cancer Research.

[26]  E. Stanley,et al.  Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. , 2002, Cancer research.

[27]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[28]  Michael C. Ostrowski,et al.  A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. , 2003, Blood.

[29]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[30]  Jeffrey W Pollard,et al.  Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. , 2003, The American journal of pathology.

[31]  J. Pollard Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[32]  L. Trümper,et al.  Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. , 2004, Carcinogenesis.

[33]  J. Pollard,et al.  A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.

[34]  A. Chambers,et al.  Role of osteopontin in tumour progression , 2004, British Journal of Cancer.

[35]  L. Staudt,et al.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.

[36]  Andrew V. Nguyen,et al.  The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression , 2002, Journal of Mammary Gland Biology and Neoplasia.

[37]  A. Harris,et al.  Tumor-Associated Macrophages in Breast Cancer , 2002, Journal of Mammary Gland Biology and Neoplasia.

[38]  Masahiro Inoue,et al.  An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. , 2004, The Journal of clinical investigation.

[39]  T. Barrette,et al.  ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.

[40]  J. Gregg,et al.  Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior , 2005, Clinical & Experimental Metastasis.

[41]  Erik Sahai,et al.  Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. , 2005, Cancer research.

[42]  R. Irby,et al.  Osteopontin induces multiple changes in gene expression that reflect the six “hallmarks of cancer” in a model of breast cancer progression , 2005, Molecular carcinogenesis.

[43]  B. Nielsen,et al.  Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas. , 2005, Carcinogenesis.

[44]  T. Hagemann,et al.  Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. , 2005, Journal of immunology.

[45]  R. Mebius,et al.  Structure and function of the spleen , 2005, Nature Reviews Immunology.

[46]  Luigi Naldini,et al.  Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.

[47]  T. Hagemann,et al.  Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-κB and JNK1 , 2005, The Journal of Immunology.

[48]  S Gordon,et al.  Macrophage receptors and immune recognition. , 2005, Annual review of immunology.

[49]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[50]  B. Isaac,et al.  Syk Is Required for Monocyte/Macrophage Chemotaxis to CX3CL1 (Fractalkine)1 , 2005, The Journal of Immunology.

[51]  John Condeelis,et al.  Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.

[52]  L. Trümper,et al.  Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Pollard,et al.  Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[54]  J. Pollard,et al.  Macrophages regulate the angiogenic switch in a mouse model of breast cancer. , 2006, Cancer research.

[55]  A. Sica,et al.  A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). , 2006, Blood.

[56]  J. Pollard,et al.  Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.

[57]  S. Gordon,et al.  Ovarian Cancer Cells Polarize Macrophages Toward A Tumor-Associated Phenotype1 , 2006, The Journal of Immunology.

[58]  S. R. Himes,et al.  Mouse neutrophilic granulocytes express mRNA encoding the macrophage colony‐stimulating factor receptor (CSF‐1R) as well as many other macrophage‐specific transcripts and can transdifferentiate into macrophages in vitro in response to CSF‐1 , 2007, Journal of leukocyte biology.

[59]  T. Barrette,et al.  Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. , 2007, Neoplasia.

[60]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[61]  J. Suttles,et al.  IL-12 Rapidly Alters the Functional Profile of Tumor-Associated and Tumor-Infiltrating Macrophages In Vitro and In Vivo1 , 2007, The Journal of Immunology.

[62]  Yarong Wang,et al.  Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. , 2007, Cancer research.

[63]  Alberto Mantovani,et al.  Inflammation and cancer: breast cancer as a prototype. , 2007, Breast.

[64]  J. Pollard,et al.  Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages , 2007, Molecular oncology.

[65]  N. Minato,et al.  SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion , 2007, Nature Genetics.

[66]  J. Pollard,et al.  Tumor-associated macrophages press the angiogenic switch in breast cancer. , 2007, Cancer research.

[67]  D. Hume,et al.  Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter. , 2007, Developmental biology.

[68]  L. Rodrigues,et al.  The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[69]  P. Comoglio,et al.  Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages , 2008, The Journal of experimental medicine.

[70]  T. Lawrence,et al.  “Re-educating” tumor-associated macrophages by targeting NF-κB , 2008, The Journal of experimental medicine.

[71]  D. Ovchinnikov Macrophages in the embryo and beyond: Much more than just giant phagocytes , 2008, Genesis.

[72]  D. Carbone,et al.  Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. , 2008, Cancer cell.

[73]  H. Saya,et al.  Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastric tumour cells , 2008, The EMBO journal.

[74]  V. Bronte,et al.  Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells , 2008, Immunological reviews.

[75]  Michelle Collazo,et al.  Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.

[76]  R. Weinberg,et al.  Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin , 2008, Cell.